Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Works of Ariel E. Birnbaum being referenced
innovaTV 207: New combination dosing cohorts in the open label phase 2 study of tisotumab vedotin in solid tumors.
2022
First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ariel E. Birnbaum | 110 | 115 | 35 | 59 | 25 | 268 | |
| Ina Valeria Zurlo | 99 | 85 | 29 | 42 | 23 | 181 | |
| Davide Tomasini | 77 | 104 | 19 | 37 | 25 | 268 | |
| Ulisses Ribaldo Nicolau | 82 | 107 | 55 | 39 | 28 | 234 | |
| Jean Philippe Metges | 217 | 119 | 7 | 82 | 23 | 332 | |
| Gregory Vlacich | 82 | 142 | 77 | 128 | 22 | 301 | |
| Matthias Schauer | 110 | 173 | 10 | 136 | 23 | 321 | |
| Binnari Kim | 134 | 115 | 11 | 70 | 28 | 277 | |
| Bo Wei | 68 | 125 | 7 | 47 | 30 | 297 | |
| Maria Antista | 188 | 89 | 5 | 65 | 25 | 274 | |
| Myoung Won Son | 99 | 97 | 4 | 56 | 28 | 249 |
All Works
Loading papers...